Pacific Biosciences of California, Inc. (PACB)
NASDAQ: PACB · Real-Time Price · USD
1.390
+0.010 (0.72%)
At close: Mar 9, 2026, 4:00 PM EDT
1.400
+0.010 (0.72%)
After-hours: Mar 9, 2026, 6:27 PM EDT

PACB Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2016
Market Capitalization
4205655392,6241,8504,513
Upgrade
Market Cap Growth
-6.53%4.82%-79.47%41.85%-59.02%-6.61%
Upgrade
Enterprise Value
8239699882,7921,9644,387
Upgrade
Last Close Price
1.381.871.839.818.1820.46
Upgrade
PS Ratio
2.503.533.5013.0814.4234.58
Upgrade
PB Ratio
77.90105.551.063.743.295.71
Upgrade
EV/Sales Ratio
5.146.066.4213.9315.3033.61
Upgrade
Debt / Equity Ratio
131.32131.321.331.331.691.21
Upgrade
Net Debt / Equity Ratio
79.0679.060.560.430.31-0.11
Upgrade
Net Debt / EBITDA Ratio
-2.50-2.50-1.13-1.04-0.600.52
Upgrade
Net Debt / FCF Ratio
-3.71-3.71-1.33-1.13-0.630.76
Upgrade
Asset Turnover
0.160.160.100.110.070.11
Upgrade
Inventory Turnover
1.951.951.842.662.003.68
Upgrade
Quick Ratio
4.324.326.307.033.0014.90
Upgrade
Current Ratio
5.155.157.487.813.2415.36
Upgrade
Return on Equity (ROE)
-213.45%-213.45%-51.30%-48.53%-46.42%-32.17%
Upgrade
Return on Assets (ROA)
-33.73%-33.73%-12.08%-11.04%-10.10%-9.20%
Upgrade
Return on Capital Employed (ROCE)
-77.60%-77.60%-24.30%-18.80%-20.30%-9.20%
Upgrade
Earnings Yield
-136.54%-96.78%-57.53%-11.69%-16.99%-4.01%
Upgrade
FCF Yield
-28.47%-20.18%-39.41%-10.21%-15.14%-2.60%
Upgrade
Buyback Yield / Dilution
-9.28%-9.28%-8.22%-12.95%-10.00%-16.67%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.